FDx Advisors’s Exelixis EXEL Stock Holding History

FDx Advisors’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-11,458	Closed	-$273K	–	809
2019 Q1	$273K	Buy	+11,458	New	+$261K	0.01%	631

Other funds holding EXEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

FDx Advisors's EXEL Position: Q2 2019 in Review

FDx Advisors sold out of Exelixis (EXEL) in Q2 2019, closing a stake of 11,458 shares — an estimated $273K sold.

FDx Advisors first reported a position in EXEL in Q1 2019 and held it in 1 quarter. The position peaked at $273K in Q1 2019. 346 funds tracked by Wall St. Rank hold EXEL as of Q2 2019.

FDx Advisors reported no remaining Exelixis position as of Q2 2019 after selling out during the quarter.
FDx Advisors sold 11,458 Exelixis shares in Q2 2019, an estimated $273K.
FDx Advisors first reported a position in Exelixis in Q1 2019 and held it in 1 quarter.
FDx Advisors's Exelixis position peaked at $273K in Q1 2019.
346 funds tracked by Wall St. Rank held Exelixis as of Q2 2019.

Based on FDx Advisors's 13F filing for Q2 2019, filed 19 Jul 2019.